Pfizer Animal Health has launched Zylexis for horses, the first and only immunomodulator licensed in the UK

Zylexis contains inactivated parapox ovis virus (iPPOV), a super-antigen that boosts a horse’s immune system to reduce the effects of infectious respiratory disease.

Zylexis works by stimulating the horse’s non-specific immune system, inducing antiviral interferons and interleukins and stimulating innate immune cells. In this way it bridges the gap until the horse’s adaptive immune system can develop a pathogen-specific response.

For more information visit Pfizer.